Blazar BR - Search Results

1

Differential effects of proteasome inhibition by bortezomib on murine acute graft-versus-host disease (GVHD): delayed administration of bortezomib results in increased GVHD-dependent gastrointestinal toxicity.

Sun K, Wilkins DE, Anver MR, Sayers TJ, Panoskaltsis-Mortari A, Blazar BR, Welniak LA, Murphy WJ. Sun K, et al. Among authors: blazar br. Blood. 2005 Nov 1;106(9):3293-9. doi: 10.1182/blood-2004-11-4526. Epub 2005 Jun 16. Blood. 2005. PMID: 15961519 Free PMC article.

2

Prevention of murine graft-versus-host disease and bone marrow alloengraftment across the major histocompatibility barrier after donor graft preincubation with anti-LFA1 immunotoxin.

Blazar BR, Carroll SF, Vallera DA. Blazar BR, et al. Blood. 1991 Dec 1;78(11):3093-102. Blood. 1991. PMID: 1954395 Free article.

3

Pretreatment of murine donor grafts with L-leucyl-L-leucine methyl ester: elimination of graft-versus-host disease without detrimental effects on engraftment.

Blazar BR, Thiele DL, Vallera DA. Blazar BR, et al. Blood. 1990 Feb 1;75(3):798-805. Blood. 1990. PMID: 1967541 Free article.

4

Toxicity and efficacy of anti-T-cell ricin toxin A chain immunotoxins in a murine model of established graft-versus-host disease induced across the major histocompatibility barrier.

Vallera DA, Carroll SF, Snover DC, Carlson GJ, Blazar BR. Vallera DA, et al. Among authors: blazar br. Blood. 1991 Jan 1;77(1):182-94. Blood. 1991. PMID: 1984794 Free article.

5

Use of an anti-pan T-lymphocyte ricin a chain immunotoxin in steroid-resistant acute graft-versus-host disease.

Byers VS, Henslee PJ, Kernan NA, Blazar BR, Gingrich R, Phillips GL, LeMaistre CF, Gilliland G, Antin JH, Martin P, et al. Byers VS, et al. Among authors: blazar br. Blood. 1990 Apr 1;75(7):1426-32. Blood. 1990. PMID: 2180494 Free article. Clinical Trial.

6

Treatment of moderate/severe acute graft-versus-host disease after allogeneic bone marrow transplantation: an analysis of clinical risk features and outcome.

Weisdorf D, Haake R, Blazar B, Miller W, McGlave P, Ramsay N, Kersey J, Filipovich A. Weisdorf D, et al. Blood. 1990 Feb 15;75(4):1024-30. Blood. 1990. PMID: 2302454 Free article.

7

Acute upper gastrointestinal graft-versus-host disease: clinical significance and response to immunosuppressive therapy.

Weisdorf DJ, Snover DC, Haake R, Miller WJ, McGlave PB, Blazar B, Ramsay NK, Kersey JH, Filipovich A. Weisdorf DJ, et al. Blood. 1990 Aug 1;76(3):624-9. Blood. 1990. PMID: 2378989 Free article.

8

Therapy for ongoing graft-versus-host disease induced across the major or minor histocompatibility barrier in mice with anti-CD3F(ab')2-ricin toxin A chain immunotoxin.

Vallera DA, Taylor PA, Panoskaltsis-Mortari A, Blazar BR. Vallera DA, et al. Among authors: blazar br. Blood. 1995 Dec 1;86(11):4367-75. Blood. 1995. PMID: 7492798 Free article.

9

In vivo blockade of CD28/CTLA4: B7/BB1 interaction with CTLA4-Ig reduces lethal murine graft-versus-host disease across the major histocompatibility complex barrier in mice.

Blazar BR, Taylor PA, Linsley PS, Vallera DA. Blazar BR, et al. Blood. 1994 Jun 15;83(12):3815-25. Blood. 1994. PMID: 7515723 Free article.

10

Coblockade of the LFA1:ICAM and CD28/CTLA4:B7 pathways is a highly effective means of preventing acute lethal graft-versus-host disease induced by fully major histocompatibility complex-disparate donor grafts.

Blazar BR, Taylor PA, Panoskaltsis-Mortari A, Gray GS, Vallera DA. Blazar BR, et al. Blood. 1995 May 1;85(9):2607-18. Blood. 1995. PMID: 7537122 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

902 results

Search Page

Filters